Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Amortizatization of Intangibles: 2015-2024

Historic Amortizatization of Intangibles for Fortress Biotech (FBIO) over the last 10 years, with Dec 2024 value amounting to $3.4 million.

  • Fortress Biotech's Amortizatization of Intangibles rose 30.71% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 26.87%. This contributed to the annual value of $3.4 million for FY2024, which is 9.89% down from last year.
  • As of FY2024, Fortress Biotech's Amortizatization of Intangibles stood at $3.4 million, which was down 9.89% from $3.8 million recorded in FY2023.
  • Fortress Biotech's Amortizatization of Intangibles' 5-year high stood at $5.6 million during FY2020, with a 5-year trough of $3.4 million in FY2024.
  • For the 3-year period, Fortress Biotech's Amortizatization of Intangibles averaged around $3.8 million, with its median value being $3.8 million (2023).
  • As far as peak fluctuations go, Fortress Biotech's Amortizatization of Intangibles surged by 69.29% in 2020, and later slumped by 30.38% in 2021.
  • Over the past 5 years, Fortress Biotech's Amortizatization of Intangibles (Yearly) stood at $5.6 million in 2020, then crashed by 30.38% to $3.9 million in 2021, then increased by 9.27% to $4.3 million in 2022, then fell by 11.15% to $3.8 million in 2023, then decreased by 9.89% to $3.4 million in 2024.